Is nevirapine-based therapy discontinuation in hepatitis C co-infected patients a more important mortality determinant than hypersensitivity: authors' reply

AIDS. 2008 Feb 19;22(4):548-9. doi: 10.1097/QAD.0b013e3282f4a0ed.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Drug Hypersensitivity / etiology*
  • HIV Infections / mortality
  • Hepatitis C, Chronic / mortality
  • Humans
  • Nevirapine / adverse effects*

Substances

  • Anti-HIV Agents
  • Nevirapine